Left to right: Joel Sendek, Managing Director, Senior Biotechnology Analyst, Lazard Capital Markets, Carl Gordon, Founding Partner, OrbiMed, Jason Brown, Vice President, Thomas, McNerney & Partners, and Peter Kolchinsky, Managing Director, Portfolio Manager, RA Capital Management, LLC

Keynote address "Creating the methodological framework for cancer immunotherapy success" from MD Becker Partners' 2nd Annual Cancer Immunotherapy: A Long-Awaited Reality Conference:

Life Science Digest is published by MD Becker Partners LLC, a boutique management and strategy consulting firm focusing on both public and private companies in the life science industry, including pharmaceuticals, biotechnology, and medical devices.

Interested in contributing articles to Life Science Digest? Send your request and a writing sample to: info@mdbpartners.com